Have your own idea? Try our Stock Screener
Over the last 7 days, the Healthcare Services industry has dropped 1.6%, driven by declines in Meribank Biotech and WeLeader Biomedical of 7.4% and 4.9%, respectively. On the other hand StemCyte International is actually up 6.3%. However, the industry is down 11% over the past year. Looking forward, earnings are forecast to grow by 27% annually.
Has the Taiwanese Healthcare Services Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 25 Dec 2024 | NT$85.9b | NT$39.9b | NT$2.9b | 19.8x | 30x | 2.2x |
Fri, 22 Nov 2024 | NT$80.6b | NT$39.9b | NT$2.9b | 19.2x | 28.1x | 2x |
Sun, 20 Oct 2024 | NT$83.6b | NT$39.4b | NT$2.8b | 23.4x | 29.8x | 2.1x |
Tue, 17 Sep 2024 | NT$84.5b | NT$39.4b | NT$2.8b | 22.8x | 30.1x | 2.1x |
Thu, 15 Aug 2024 | NT$84.0b | NT$39.1b | NT$2.8b | 23.1x | 30.4x | 2.2x |
Sat, 13 Jul 2024 | NT$89.3b | NT$38.9b | NT$2.8b | 22.3x | 32.1x | 2.3x |
Mon, 10 Jun 2024 | NT$87.3b | NT$38.9b | NT$2.8b | 23x | 31.4x | 2.2x |
Wed, 08 May 2024 | NT$86.0b | NT$38.7b | NT$2.7b | 21.2x | 31.3x | 2.2x |
Fri, 05 Apr 2024 | NT$88.9b | NT$38.9b | NT$2.8b | 22.4x | 31.4x | 2.3x |
Sun, 03 Mar 2024 | NT$91.4b | NT$37.9b | NT$2.8b | 23.7x | 32.7x | 2.4x |
Tue, 30 Jan 2024 | NT$87.6b | NT$37.1b | NT$2.8b | 23.4x | 31.8x | 2.4x |
Thu, 28 Dec 2023 | NT$83.2b | NT$37.1b | NT$2.8b | 23.7x | 30.2x | 2.2x |
Sat, 25 Nov 2023 | NT$84.3b | NT$37.1b | NT$2.8b | 24.1x | 30.6x | 2.3x |
Mon, 23 Oct 2023 | NT$85.0b | NT$37.0b | NT$2.9b | 24.1x | 29.2x | 2.3x |
Wed, 20 Sep 2023 | NT$90.2b | NT$37.0b | NT$2.9b | 25.6x | 31x | 2.4x |
Fri, 18 Aug 2023 | NT$91.0b | NT$36.9b | NT$2.9b | 25x | 31x | 2.5x |
Sun, 16 Jul 2023 | NT$94.4b | NT$37.4b | NT$3.0b | 23.7x | 31.8x | 2.5x |
Tue, 13 Jun 2023 | NT$91.3b | NT$37.0b | NT$3.0b | 25.3x | 30.4x | 2.5x |
Thu, 11 May 2023 | NT$97.2b | NT$36.7b | NT$3.0b | 24.2x | 31.9x | 2.6x |
Sat, 08 Apr 2023 | NT$89.2b | NT$37.1b | NT$3.2b | 19.1x | 27.6x | 2.4x |
Mon, 06 Mar 2023 | NT$83.8b | NT$36.3b | NT$3.3b | 18.9x | 25.4x | 2.3x |
Wed, 01 Feb 2023 | NT$77.2b | NT$36.5b | NT$3.3b | 18x | 23.4x | 2.1x |
Fri, 30 Dec 2022 | NT$71.5b | NT$36.5b | NT$3.3b | 16.3x | 21.7x | 2x |
Sun, 27 Nov 2022 | NT$66.8b | NT$36.5b | NT$3.3b | 16.7x | 20.2x | 1.8x |
Tue, 25 Oct 2022 | NT$62.4b | NT$35.4b | NT$3.1b | 16.8x | 20x | 1.8x |
Thu, 22 Sep 2022 | NT$71.7b | NT$35.4b | NT$3.1b | 18.8x | 22.9x | 2x |
Sat, 20 Aug 2022 | NT$74.0b | NT$35.3b | NT$3.1b | 18.7x | 23.8x | 2.1x |
Mon, 18 Jul 2022 | NT$67.1b | NT$33.6b | NT$2.9b | 17.4x | 22.9x | 2x |
Wed, 15 Jun 2022 | NT$67.7b | NT$33.6b | NT$2.9b | 19.6x | 23.1x | 2x |
Fri, 13 May 2022 | NT$63.4b | NT$33.0b | NT$2.8b | 18.9x | 22.7x | 1.9x |
Sun, 10 Apr 2022 | NT$67.1b | NT$33.0b | NT$2.9b | 20.2x | 23.5x | 2x |
Tue, 08 Mar 2022 | NT$63.9b | NT$32.4b | NT$2.5b | 22.7x | 25.7x | 2x |
Thu, 03 Feb 2022 | NT$58.9b | NT$32.3b | NT$2.5b | 20.8x | 23.7x | 1.8x |
Sat, 01 Jan 2022 | NT$60.6b | NT$32.3b | NT$2.5b | 20.3x | 24.4x | 1.9x |
24.4x
Which industries have driven the changes within the Taiwanese Healthcare industry?
TW Market | 0.46% | |
Healthcare | 2.74% | |
Healthcare Services | 0.31% | |
Healthcare Services | 0.96% | |
Managed Healthcare | 0% | |
Healthcare Distributors | -0.013% | |
Healthcare Facilities | -2.20% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
4178 StemCyte International | NT$37.50 | 14.0% +NT$876.4m | n/a | n/a | |
4164 CHC Healthcare Group | NT$41.50 | 1.5% +NT$100.1m | -31.3% | PE21.4x | |
7713 WeLeader Biomedical | NT$81.20 | 1.5% +NT$49.9m | n/a | n/a | |
1788 Hi-Clearance | NT$139.50 | 0.4% +NT$22.3m | 3.0% | PE16.8x | |
6130 Shangya Technology | NT$24.00 | 1.7% +NT$17.7m | -31.9% | PS5.1x |